tirzepatide news november 2025 In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL New Tirzepatide Access and Pricing

Our physicians monitor you continuously to ensure your safety, screen for any health changes, and adjust your care as needed throughout your treatment journey

If you have access to insurance through your job, employer plans often have broader coverage for weight loss medications

The genomic landscape of endocrine-resistant advanced breast cancers

TKP2021-EGA-16, implemented with the support provided from the National Research, Development and Innovation Fund of Hungary, financed under the TKP2021-EGA funding scheme

Under medical supervision, IV or injectable forms are preferred for patients seeking noticeable brightening as part of a controlled skin fair treatment plan